Prior to a game against the Houston Rockets, the 76ers announced star center Joel Embiid will have surgery after being ...
Philadelphia 76ers center Joel Embiid. © Bill Streicher-Imagn Images After the 76ers announced that Embiid would undergo ...
Joel Embiid had an appendectomy in Houston after Philadelphia’s star big man was stricken with appendicitis overnight. The ...
Wed, February 25, 2026 at 5:15 PM UTC AMDY does not hold shares of Advanced Micro Devices (NASDAQ:AMD) directly. Instead, it runs a synthetic covered call strategy, using options to replicate AMD ...
A single injection of the tyrosine kinase inhibitor hydrogel has demonstrated superiority to aflibercept 2 mg in maintaining visual acuity and providing higher rescue-free rates through 1 year in ...
BEDFORD, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today ...
Detailed SOL-1 data to be presented at the 49(th) Macula Society Annual Meeting BEDFORD, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular"), an integrated ...
Investors with a lot of money to spend have taken a bullish stance on Advanced Micro Devices (NASDAQ:AMD). And retail traders should know. We noticed this today when the trades showed up on publicly ...
Ocular Therapeutix targets retinal diseases, focusing on wet age-related macular degeneration (AMD) with its lead candidate, AXPAXLI (OTX-TKI). Current wet AMD treatment is dominated by anti-VEGF ...
There's been extensive debate over the risk of neovascular age-related macular degeneration (AMD) after cataract surgery. In a large retrospective cohort study, the risk of neovascular AMD was similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results